Bellevue F (Lux) Bellevue Obesity Solutions B EUR
WKNA0X8YU
AssetklasseAktien
619,593€+5,15€
27.02.2026 21:47+ 0,84%
619,593€+5,15€
27.02.2026 21:47+ 0,84%
Verkaufen
619,593VerkaufenStück: 20Kaufen
636,32KaufenStück: 20Eröffnung
612,539
Hoch
619,593
Tief
612,539
Fund seeks to achieve long-term capital growth by investing at least two-thirds of the net assets in a portfolio of carefully chosen shares and preference shares of companies whose business is directed towards the prevention and treatment of overweight or obesity and their secondary conditions or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. The Fund invests in biotech equities worldwide but mainly US.
Emittent
Waystone Management Company (Lux) SA
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
33,546
Gesamtkostenquote (TER)
2,17 %
Tracking Difference
1,3934
Replikation
-
Fondswährung
EUR
Domizil
LU
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
623,19
NAV Datum
25.2.2026